PTC Therapeutics, Inc.NASDAQ: PTCT

PTC Therapeutics to Participate in Upcoming Investor Conferences

· Issued by PTC Therapeutics, Inc. via PR Newswire

Summary by 6ix AI

PTC Therapeutics, a biopharmaceutical company developing medicines for rare disorders, said its executives will speak at the Jefferies Global Healthcare Conference on Monday, November 16 at 11 a.m. GMT/6 a.m. ET and the Citi 2026 Global Healthcare Conference on Tuesday, December 1 at 9:40 a.m. ET.

Key details

  • The presentations will be webcast live on the Events and Presentations page in the Investor section of the PTC Therapeutics website and archived for 30 days after each presentation.

6ix AI wrote this summary from the release below and checked it against the release.

WARREN, N.J., Nov. 2, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

PTC Therapeutics, Inc. Logo

Jefferies Global Healthcare Conference 
Monday, Nov. 16 at 11 a.m. GMT/6 a.m. ET

Citi 2026 Global Healthcare Conference
Tuesday, Dec. 1 at 9:40 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.

About PTC Therapeutics, Inc. 
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook and Instagram.

For more information, please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-6228
[email protected]

Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302925133.html

SOURCE PTC Therapeutics, Inc.

View original source (PR Newswire)PTC Therapeutics, Inc. on 6ix

Story so far

Earlier from PTC Therapeutics

Later from PTC Therapeutics

All PTC Therapeutics news releases